NZORD’s submission on Pharmac’s decision criteria

1 September 2013

This submission on Pharmac’s consultation on its decision criteria, reflects many of the issues we raised in our recent submission on eculizumab, but with some amendments for context, some additional comment on several of the major themes in the earlier submission, and more general discussion about Pharmac’s responsibilities and the approach it should take to fulfilling them.

It also contains a brief summary of the political parties’ response at our August seminar, and the new reality of an Orphan Drugs Access programme for NZ being squarely on the political agenda.

Click here to read the full submission.